Public Profile

Cogentix Medical, Inc.

Cogentix Medical, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in 2010, the company has established itself as a leader in developing innovative solutions for urological and gynaecological conditions. With a focus on minimally invasive procedures, Cogentix Medical offers unique products such as the Urgent® PC Neuromodulation System, which stands out for its efficacy in treating overactive bladder. The company operates primarily in North America, with a growing presence in international markets. Notable achievements include the successful integration of advanced technologies that enhance patient outcomes and streamline clinical workflows. Cogentix Medical's commitment to quality and innovation positions it as a trusted partner in the healthcare sector, dedicated to improving the lives of patients through cutting-edge medical solutions.

DitchCarbon Score

How does Cogentix Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Cogentix Medical, Inc.'s score of 18 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.

97%

Cogentix Medical, Inc.'s reported carbon emissions

Cogentix Medical, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific climate commitments outlined. As such, there are no reported figures regarding their carbon emissions in kg CO2e, nor are there established reduction targets or initiatives. In the absence of specific emissions data, it is unclear how the company is addressing climate change or its carbon footprint. This lack of information highlights a potential area for improvement in transparency regarding environmental impact and sustainability efforts within the medical device industry.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cogentix Medical, Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Cogentix Medical, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Cogentix Medical, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Olympus

JP
Electrical machinery and apparatus n.e.c. (31)
Updated 2 days ago

Allergan

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Utah Medical Products, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Coloplast

DK
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Contura International A/S

DK
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers